Filing Details
- Accession Number:
- 0001209191-19-011991
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-02-21 16:21:00
- Reporting Period:
- 2019-02-19
- Accepted Time:
- 2019-02-21 16:21:00
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1550395 | David Altshuler | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp, Global Research And Cso | No | Yes | No | No |
Transaction Summary
Sold: | 5,624 shares | Avg. Price: $187.00 | Total Value: $1,051,715.53 |
Number of Shares After Transactions: | 31,553 shares |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2019-02-19 | 4,573 | $186.81 | 32,604 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-02-19 | 651 | $187.40 | 31,953 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-02-19 | 400 | $188.59 | 31,553 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $186.81 (range $186.09 to $187.08).
- Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $187.40 (range $187.12 to $187.96).
- Open market sales reported on this line occurred at a weighted average price of $188.59 (range $188.36 to $188.86).